Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years
Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women
Two Pivotal Phase 3 studies demonstrated Tonmya significantly reduced fibromyalgia pain compared to placebo; generally well tolerated
https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-fda-approval-194400374.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.